Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inibsa Dental is a prominent pharmaceutical company dedicated to the dental healthcare sector, recognized as a global leader in the production of dental anesthetics. Based in Spain, the company operates as a specialized business unit of the Inibsa Group, leveraging over 75 years of experience in the pharmaceutical industry. Its core product portfolio includes high-quality local anesthetics such as articaine, lidocaine, and mepivacaine, which are manufactured in its advanced sterile injectable facility. Beyond anesthesia, Inibsa Dental provides comprehensive solutions for infection control, oral surgery, and restorative dentistry to professionals worldwide. The company exports its products to more than 60 countries, maintaining a significant market share in Europe and Latin America. With a commitment to quality and innovation, Inibsa Dental operates under strict GMP standards to ensure the safety and efficacy of its dental medical devices and pharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inibsa Dental.